Piramal Pharma shares rose 32% in the last six weeks, reaching a new high in 18 months. Despite the recent uptrend, the stock remains 24% below its IPO price. The company has recently expanded into men s grooming products, aiming to enhance self-care practices.
Piramal Pharma Consumer Products Division launches Wellify in, an in-house D2C platform for health and wellness products webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.